BlueCrest Capital Management increased its stake in Calumet Specialty Products Partners by 33.3%, purchasing 20,000 shares valued at $2.88 million. The stock rose 3.3% amid broader institutional inter
UBS Asset Management Americas increased its stake in Calumet, Inc. by 19.5% in Q2, now holding shares valued at $5.6 million. The company reported 40.8% year-over-year revenue growth despite missing e
Concurrent Investment Advisors LLC acquired 57,380 shares of Calumet Specialty Products Partners worth approximately $2.07 million in Q2. Institutional holdings total 34.41%, though the company report
Legal & General Group Plc acquired a 0.06% stake in Calumet Specialty Products Partners for approximately $1.73 million. Despite strong revenue growth, Calumet missed earnings estimates, leading to mi
Manufacturers Life Insurance Company invested $1.07 million acquiring 29,852 shares of Calumet Specialty Products Partners. Institutional holdings stand at 34.41%, though analyst ratings remain mixed
Calumet Specialty Products Partners reached a new 52-week high of $51.57 despite an adjusted loss of $1.09 per share. Quarterly revenue rose 40.8% year-over-year to $1.45 billion, while analysts maint
Two Seas Capital LP acquired over 6.6 million shares worth $238.4 million in Calumet, Inc., making it their third-largest holding. Despite revenue growth, the company missed earnings estimates, mainta
Russell Investments Group Ltd. increased its stake in Calumet Specialty Products Partners by 239.4%, purchasing 30,990 shares. Calumet reported a 40.8% revenue increase but missed earnings expectation
Two Seas Capital LP reported a 7.5% beneficial ownership stake in Calumet Specialty Products Partners via its Two Seas Global Fund. The Schedule 13G/A filing indicates sole voting power over approxima
Janus Henderson Group PLC increased its stake in Calumet Specialty Products Partners by 596.3% in Q1, acquiring 186,648 shares worth $7.8 million. This follows Calumet's quarterly earnings miss, thoug
First Trust Advisors LP increased its stake in Calumet Specialty Products Partners by 36.2%, bringing total holdings to $12.475 million. Analysts maintain a 'Hold' rating with a consensus price target
Calumet Specialty Products Partners will report Q2 2026 earnings on August 7th, with analysts expecting $0.0674 per share and $1.11 billion in revenue. Despite recent stock gains, market sentiment rem
ChemBrief